US2016362662A1PendingUtilityA1

Modified Leucine Dehydrogenase

Assignee: AJINOMOTO KKPriority: Mar 30, 2012Filed: Aug 29, 2016Published: Dec 15, 2016
Est. expiryMar 30, 2032(~5.7 yrs left)· nominal 20-yr term from priority
C12N 9/0016C12P 13/08C12P 13/06C12Y 104/01009C12P 13/04C07K 2319/02C12Q 1/32G01N 33/6812G01N 2333/90616C12N 15/66G01N 33/68C12Q 1/005
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides a means and method useful for measurement of a total branched-chain amino acid concentration. Specifically, the present invention provides a modified enzyme in which at least one amino acid residue is mutated so as to improve a property of a leucine dehydrogenase which is associated with the measurement of the total branched-chain amino acids, such as, for example, substrate specificities of leucine dehydrogenase for total branched-chain amino acids, activity of leucine dehydrogenase for any branched-chain amino acids, and thermal stability of leucine dehydrogenase; and a method of analyzing the total branched-chain amino acids, comprising measuring the total branched-chain amino acids contained in a test sample using the modified enzyme.

Claims

exact text as granted — not AI-modified
1 . A method of producing a derivative of a branched-chain amino acid, comprising producing the derivative from the branched-chain amino acid using a modified leucine dehydrogenase enzyme,
 wherein said modified leucine dehydrogenase enzyme comprises at least one amino acid mutation as compared to a non-modified leucine dehydrogenase enzyme, wherein said modified leucine dehydrogenase is improved in one or more properties selected from the group consisting of:   (a) substrate specificities for L-leucine, L-isoleucine and L-valine;   (b) activity for any branched-chain amino acid;   (c) thermal stability, and   (d) combinations thereof,   wherein said modified leucine dehydrogenase is selected from the group consisting of:   (A) a protein comprising an amino acid sequence of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, or SEQ ID NO: 8, but having a substitution of isoleucine in the TGI motif with an amino acid selected from the group consisting of methionine, arginine, histidine, phenylalanine, leucine, lysine, cysteine, tyrosine, alanine, glycine, serine, asparagine, and tryptophan,   (B) a protein comprising an amino acid sequence of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, or SEQ ID NO: 8, but having a substitution of isoleucine in the GVI motif with an amino acid selected from the group consisting of phenylalanine, histidine, asparagine, tyrosine, leucine, lysine, glutamine, arginine, aspartic acid, threonine, glutamic acid, serine, cysteine, alanine, glycine, valine, tryptophan, and methionine,   (C) a protein comprising an amino acid sequence of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, or SEQ ID NO: 8, but having a substitution of isoleucine in the TGI motif with an amino acid selected from the group consisting of methionine, arginine, histidine, phenylalanine, leucine, lysine, cysteine, tyrosine, alanine, glycine, serine, asparagine, and tryptophan, and a substitution of isoleucine in the GVI motif with an amino acid selected from the group consisting of phenylalanine, histidine, asparagine, tyrosine, leucine, lysine, glutamine, arginine, aspartic acid, threonine, glutamic acid, serine, cysteine, alanine, glycine, valine, tryptophan, and methionine, and   (D) a protein as described in (A), (B), or (C) above, but also comprising one to ten additional mutations of amino acid residues.

Join the waitlist — get patent alerts

Track US2016362662A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.